Ally Bridge Group (Ny) LLC Portfolio Holdings

Ally Bridge Group (Ny) LLC

  • $114 Million
  • Q1 2024

Ally Bridge Group (Ny) LLC has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $114 Million distributed in 22 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Blueprint Medicines Corp with a value of $15.3M, Xenon Pharmaceuticals Inc. with a value of $13.3M, Verona Pharma PLC with a value of $11.9M, Merus N.V. with a value of $11.5M, and Avadel Pharmaceuticals PLC with a value of $9.24M.

Examining the 13F form we can see an decrease of $3.23M in the current position value, from $117M to 114M.

Ally Bridge Group (Ny) LLC is based out at New York, NY

Below you can find more details about Ally Bridge Group (Ny) LLC portfolio as well as his latest detailed transactions.

Portfolio value $114 Million
Healthcare: $112 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$6.3B
$15.3 Million 13.43% of portfolio
160,950
Q1 2024 New
$2.37B
$13.3 Million 11.72% of portfolio
309,369
Q1 2024 Added 27.86%
$736M
$11.9 Million 10.43% of portfolio
736,738
Q1 2024 New
$2.44B
$11.5 Million 10.14% of portfolio
255,928
Q1 2024 Reduced 6.91%
$966M
$9.24 Million 8.13% of portfolio
547,036
Q1 2024 Added 57.63%
$1.34B
$9.11 Million 8.01% of portfolio
2,760,497
Q1 2024 Reduced 7.11%
$1.38B
$7.79 Million 6.85% of portfolio
365,044
Q1 2024 New
$7.46B
$6.78 Million 5.97% of portfolio
250,000
Q1 2024 New
$391M
$6.33 Million 5.57% of portfolio
559,035
Q1 2024 Reduced 15.17%
$10.5M
$6.24 Million 5.49% of portfolio
1,003,741
Q1 2024 New
$256M
$5.84 Million 5.14% of portfolio
270,559
Q1 2024 New
$119M
$3.77 Million 3.32% of portfolio
420,000
Q1 2024 New
$226M
$3.59 Million 3.16% of portfolio
801,437
Q1 2024 New
$0
$2.02 Million 1.78% of portfolio
1,059,582
Q1 2024 Reduced 0.66%
$31.6M
$1 Million 0.88% of portfolio
725,951
Q3 2023 Added 11.1%
Mind Medicine Mindmed Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Dianthus Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Jasper Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Soleno Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 Added 8.56%
Cg Oncology Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Marinus Pharmaceuticals Inc
-
$0 0.0% of portfolio
-
Q1 2024 New

Summary

  • Portfolio
  • No. of Stocks 22
  • Current Value $114 Million
  • Prior Value $117 Million
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 13 stocks
  • Additional Purchases 4 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Ally Bridge Group (Ny) LLC Portfolio

Follow Ally Bridge Group (Ny) LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email